Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2021 Nov;195(3):466-468.
doi: 10.1111/bjh.17759. Epub 2021 Aug 6.

Plasmablastic lymphoma transformation in a patient with Waldenström macroglobulinemia treated with ibrutinib

Jorge J Castillo  1   2 , John LaMacchia  2   3 , Catherine A Flynn  1 , Shayna Sarosiek  1   2 , Olga Pozdnyakova  2   3 , Steven P Treon  1   2
Affiliations
Case Reports

Plasmablastic lymphoma transformation in a patient with Waldenström macroglobulinemia treated with ibrutinib

Jorge J Castillo et al. Br J Haematol. 2021 Nov.
No abstract available

Keywords: Waldenstrom-s macroglobulinaemia; ibrutinib; plasmablastic lymphoma.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

References

    1. Castillo JJ, Gustine J, Meid K, Dubeau T, Hunter ZR, Treon SP. Histological transformation to diffuse large B-cell lymphoma in patients with Waldenstrom macroglobulinemia. Am J Hematol. 2016;91(10):1032-5.
    1. Zanwar S, Abeykoon JP, Durot E, King R, Perez Burbano GE, Kumar S, et al. Impact of MYD88(L265P) mutation status on histological transformation of Waldenstrom macroglobulinemia. Am J Hematol. 2020;95(3):274-81.
    1. Owen RG, Bynoe AG, Varghese A, de Tute RM, Rawstron AC. Heterogeneity of histological transformation events in Waldenstrom's macroglobulinemia (WM) and related disorders. Clin Lymphoma Myeloma Leuk. 2011;11(1):176-9.
    1. Castillo JJ, Furman M, Beltrán BE, Bibas M, Bower M, Chen W, et al. Human immunodeficiency virus-associated plasmablastic lymphoma: poor prognosis in the era of highly active antiretroviral therapy. Cancer. 2012;118(21):5270-7.
    1. Castillo JJ, Guerrero-Garcia T, Baldini F, Tchernonog E, Cartron G, Ninkovic S, et al. Bortezomib plus EPOCH is effective as frontline treatment in patients with plasmablastic lymphoma. Br J Haematol. 2019;184(4):679-82.

MeSH terms

Supplementary concepts

LinkOut - more resources